Abstract:Abstract Rationale The extracellular matrix (ECM) initiates mechanical cues and transduces intracellular signaling through matrix-cell interactions. In the blood vessels, additional mechanical cues derived from the pulsatile blood flow and pressure play a pivotal role in homeostasis and disease development. Currently, the nature of the cues from ECM and how they coordinate with a mechanical microenvironment in large blood vessels to maintain the integrity of the vessel wall are not fully understood. Objective The aim of this study was to elucidate the crucial mediator(s) and molecular signaling pathway(s) involved in matrix mechanotransduction during remodeling of the vessel wall. Methods and Results We performed secretome analysis using rat vascular smooth muscle cells (SMCs) under cyclic stretch and examined matrix-cell interactions and cell behavior. We found that the matricellular protein thrombospondin-1 (Thbs1) was secreted upon cyclic stretch and bound to integrin αvβ1, thereby recruiting vinculin and establishing focal adhesions. RNA-sequence (RNA-seq) analysis revealed that deletion of Thbs1 in vitro markedly affected the target gene expression of Yes-associated protein (YAP). Consistently, we found that Thbs1 promotes nuclear shuttling of YAP in response to cyclic stretch, which depends on the small GTPase Rap2 and Hippo pathway, and is not influenced by alteration of actin fibers. Deletion of Thbs1 in mice inhibited Thbs1/integrin/YAP signaling, leading to maladaptive remodeling of the aorta in response to pressure overload by transverse aortic constriction (TAC), whereas it suppressed neointima formation upon carotid artery ligation, exerting context-dependent effects on the vessel wall. Conclusions Thbs1 serves as a mechanical stress-triggered extracellular mediator of mechanotransduction that acts via integrin αvβ1 to establish focal adhesions and promotes nuclear shuttling of YAP. We thus propose a novel mechanism of matrix mechanotransduction centered on Thbs1, connecting mechanical stimuli to YAP signaling during vascular remodeling in vivo. Subject codes Vascular Disease Genetically Altered and Transgenic Models Vascular Biology Cell Signaling/Signal Transduction

Blood and bones: Mechanical cues and Hippo signaling drive vascular invasion during limb formation

BMP Signaling in the Development and Regeneration of Cranium Bones and Maintenance of Calvarial Stem Cells.

Tgf-Beta and Bmp Signaling in Osteoblast, Skeletal Development, and Bone Formation, Homeostasis and Disease

Biomechanical Signaling Within the Developing Zebrafish Heart Attunes Endocardial Growth to Myocardial Chamber Dimensions

Yap1 Regulates Multiple Steps of Chondrocyte Differentiation during Skeletal Development and Bone Repair

YAP/TAZ-CDC42 signaling regulates vascular tip cell migration

External Mechanical Stability Regulates Hematoma Vascularization in Bone Healing Rather than Endothelial YAP/TAZ Mechanotransduction

Integration of Mechanical and Chemical Signals by YAP and TAZ Transcription Coactivators.

The Hippo pathway effectors TAZ and YAP in development, homeostasis and disease

Mechanoregulation of YAP and TAZ in Cellular Homeostasis and Disease Progression

Lats1/2 are essential for developmental vascular remodeling and biomechanical adaptation to shear stress

Bone Morphogenetic Proteins in Vascular Homeostasis and Disease

The Hippo signalling pathway in bone homeostasis: Under the regulation of mechanics and aging

Harness the power: new insights into the inhibition of YAP/Yorkie.

Deposition of collagen type I onto skeletal endothelium reveals a new role for blood vessels in regulating bone morphology

Control of skeletal morphogenesis by the Hippo-YAP/TAZ pathway

Endothelial SMAD1/5 signaling couples angiogenesis to osteogenesis in juvenile bone

Skeletal cell YAP and TAZ combinatorially promote bone development

Matrix mechanotransduction mediated by thrombospondin-1/integrin/YAP signaling pathway in the remodeling of blood vessels

Endothelial Notch activity promotes angiogenesis and osteogenesis in bone

YAP1 and TAZ negatively control bone angiogenesis by limiting hypoxia-inducible factor signaling in endothelial cells